<b>Methods:</b> A comprehensive literature search for eligible randomized control phase II/III trials that compared the efficacy of anti-PD-1/PD-L1 agents against chemotherapy in advanced or metastatic NSCLC patients. This evidence concerns the gene CD274 and non-small cell lung carcinoma.